Osimertinib EGFR inhibitors  

Tagrisso - osimertinib      

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultdeath (overall survival) progression or death (progression free survival PFS)

lung cancer (metastatic)  

FLAURA, 2017      NCTosimertinibplacebo1LLow risk of bias suggesting -55%
AURA 3, 2017    NCTosimertinibplatinum-based therapy plus pemetrexed 2Lsuggesting-70%